Fundraising Fox

Kuros Biosciences

216 employees on LinkedIn · 1 known investors

Find your way into Kuros Biosciences

Kuros Biosciences is a Swiss biotech company developing biologic technologies for bone healing and bone grafts, primarily for spine, extremities, and pelvis surgical applications. Originally a spin-off of the Swiss Federal Institute of Technology in Zurich, it is publicly listed on the SIX Swiss Stock Exchange and operates in Switzerland, the Netherlands, and the USA.

BiotechHealthtechMedical Devices

Founders & leadership

CFChris Fair
Chris FairinCEO

Investors · 1

VI PartnersAltendorf · $2.2M – $4.5M

In the news

Kuros H1 2026 slides: 45% growth drives first profitable half-year By Investing.cominvesting.com · Aug 2026Earnings call transcript: Kuros Biosciences posts H1 2026 profit on 45% sales gain By Investing.cominvesting.com · Aug 2026CSBT.F - How a Mispriced Medtech Engine is Disrupting $5,000 Bone Graft Giants.simplywall.st · Jul 2026

Frequently asked questions

What does Kuros Biosciences do?
Kuros Biosciences is a Swiss biotech company developing biologic technologies for bone healing and bone grafts, primarily for spine, extremities, and pelvis surgical applications. Originally a spin-off of the Swiss Federal Institute of Technology in Zurich, it is publicly listed on the SIX Swiss Stock Exchange and operates in Switzerland, the Netherlands, and the USA.
Who are Kuros Biosciences's investors?
Kuros Biosciences's investors include VI Partners.